Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Timeline for construction of gas carriers for Arctic LNG-2 has been pushed back by a year
4/26/23
NVTK
Boeing reported 3 months of 2023
4/26/23
BA
TNS Energo reported for 3 months of 2023 by RAS
4/26/23
TNSE
Volgogradenergosbyt reported for 3 months of 2023 according to RAS
4/26/23
VGSB
General Dynamics reported 3 months of 2023
4/26/23
GD
Perm Power Supply Company reported for 2022 by IFRS
4/26/23
PMSB
United Medical Group reports for 2022 according to IFRS
4/26/23
GEMC
Mordovskaya Energosbytovaya Kompaniya reported for 3 months of 2023 by RAS
4/26/23
MRSB
The Visa announced a quarterly dividend
4/26/23
V
Urent electric scooters appeared in Yandex Go
4/26/23
YNDX
«
Previous
640
641
642
643
644
645
646
647
648
649
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)